Tatiana I. Novobrantseva
Papers
1
Total Citations
200
H-Index
1
About
Tatiana I. Novobrantseva is a pioneering figure in nanomedicine and drug delivery, whose work has fundamentally advanced the design of synthetic carriers for intracellular therapeutics. Her most celebrated contribution is the development of a high-throughput, combinatorial synthesis platform for chemically diverse core-shell nanoparticles. In a landmark 2011 study, Novobrantseva and her team engineered an "assembly line" approach to generate and evaluate 1,536 structurally distinct nanoparticles, systematically varying their cationic cores and surface shells. This massive, parallel screening—now cited over 200 times—enabled the first comprehensive elucidation of the complex relationships between nanoparticle chemistry, cellular internalization, and delivery efficiency. By revealing trends that could only be learned through broad empirical evaluation, her work moved nanoparticle design from trial-and-error to a rational, data-driven science. Novobrantseva’s research has had a profound impact on the field, providing a foundational toolkit for designing safer, more effective carriers for gene therapy, vaccines, and other intracellular drugs. Her innovative, modular approach continues to inspire next-generation delivery systems, making her a key architect of modern nanotherapeutic strategies.
Research Focus
Key Achievements
Top Papers
- 1